Literature DB >> 9201522

Gastrointestinal permeability following cardiopulmonary bypass: a randomised study comparing the effects of dopamine and dopexamine.

D G Sinclair1, P E Houldsworth, B Keogh, J Pepper, T W Evans.   

Abstract

OBJECTIVE: To compare the effects of dopexamine and dopamine on the mucosal permeability of the gastrointestinal tract (GIT).
DESIGN: Prospective, randomised clinical trial.
SETTING: Intensive care unit of a postgraduate teaching hospital, London, England. PATIENTS: Thirty patients undergoing elective surgery involving cardiopulmonary bypass, performed by a single surgeon.
INTERVENTIONS: Patients were randomly assigned to receive either dopexamine 2.0 micrograms/kg per min or dopamine 2.5 micrograms/kg per min for the duration of the study period.
MEASUREMENTS AND MAIN RESULTS: Hemodynamic parameters and gastric intramucosal pH (pHi) were measured at intervals throughout the study. GIT permeability was measured once, post-operatively, using the ratio of absorbed lactulose to L-rhamnose. The groups were similar with respect to demographics, pre- and post-operative risk factors. The lactulose/rhamnose ratio was (mean +/- SEM) 0.44 +/- 0.10 in the dopexamine group vs 0.65 +/- 0.08 in that receiving dopamine (p < 0.05). The dopexamine group had a significantly higher oxygen delivery preoperatively (479.5 +/- 32.0 ml/min per m2 vs 344.4 +/- 23.9 ml/min per m2 for dopamine, p < 0.01), but no other significant differences emerged between the groups.
CONCLUSIONS: Compared to dopamine, dopexamine reduces GIT permeability following surgery involving cardiopulmonary bypass. The mechanism of this effect remains unclear.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9201522     DOI: 10.1007/s001340050366

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  4 in total

1.  Intestinal permeability in adult patients with growth hormone deficiency.

Authors:  J García-Arnés; C Sierra; F Tinahones; A Monzón; M J López; N Mazuecos; F Soriguer; E Valverde
Journal:  J Endocrinol Invest       Date:  2001-02       Impact factor: 4.256

Review 2.  Monitoring the hepato-splanchnic region in the critically ill patient. Measurement techniques and clinical relevance.

Authors:  A Brinkmann; E Calzia; K Träger; P Radermacher
Journal:  Intensive Care Med       Date:  1998-06       Impact factor: 17.440

3.  Gastrointestinal permeability following cardiopulmonary bypass.

Authors:  L Bindl
Journal:  Intensive Care Med       Date:  1998-03       Impact factor: 17.440

Review 4.  Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery -- a systematic literature review.

Authors:  Michael Gillies; Rinaldo Bellomo; Laurie Doolan; Brian Buxton
Journal:  Crit Care       Date:  2004-12-16       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.